Axsome Therapeutics, Inc. (AXSM) vs Protagonist Therapeutics, Inc. (PTGX)
- Axsome Therapeutics, Inc. AXSM 157.14 −2.87%
- Protagonist Therapeutics, Inc. PTGX 128.75 −5.71%
Axsome Therapeutics, Inc. and Protagonist Therapeutics, Inc. are both Biotechnology companies. Axsome Therapeutics, Inc. and Protagonist Therapeutics, Inc. are of similar size ($8.8B and $8.5B). Axsome Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 106×. Axsome Therapeutics, Inc. grew revenue faster over the last twelve months: 56.9% against 34.8%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs −24.7%) and the higher return on invested capital (61.8% vs 0.00%). Across the 17 metrics below, Protagonist Therapeutics, Inc. leads on 12 and Axsome Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | AXSM | PTGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.24% | 100.00% | 65.16% |
| Operating margin | (23.96%) | 20.69% | 0.00% |
| Net margin | (24.68%) | 29.40% | 0.00% |
| Free cash flow margin | (9.27%) | 46.31% | 0.00% |
| Return on equity | (245.10%) | 10.98% | (56.36%) |
| Return on assets | (27.35%) | 10.34% | (48.04%) |
| Return on invested capital | 0.00% | 61.84% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack